Gilenya and Conjunctivitis - a phase IV clinical study of FDA data
We study 106,924 people who have side effects when taking Gilenya. Conjunctivitis is found, especially among people who are female, 50-59 old, have been taking the drug for 1 - 6 months, also take Vitamin d and have Depression.
The phase IV clinical study analyzes which people take Gilenya and have Conjunctivitis. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
106,924 people reported to have side effects when taking Gilenya.
Among them, 137 people (0.13%) have Conjunctivitis.
What is Gilenya?
Gilenya has active ingredients of fingolimod. It is used in multiple sclerosis. Currently, eHealthMe is studying from 110,620 Gilenya users.
What is Conjunctivitis?
Conjunctivitis (pink eye) is found to be associated with 2,294 drugs and 1,608 conditions by eHealthMe. Currently, we are studying 20,429 people who have Conjunctivitis.
Number of Gilenya and Conjunctivitis reports submitted per year:
Time on Gilenya when people have Conjunctivitis *:
Gender of people who have Conjunctivitis when taking Gilenya*:
Age of people who have Conjunctivitis when taking Gilenya *:
Common drugs people take besides Gilenya *:
Common side effects people have besides Conjunctivitis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Gilenya and have Conjunctivitis?Check whether Conjunctivitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Alroughani R, "Fingolimod-associated amenorrhea: a report of three cases", Multiple Sclerosis Journal, 2014 Jan .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Gilenya side effects by duration, gender and age:
- Gilenya side effects (110,620 reports)
Conjunctivitis treatments and more:
- Conjunctivitis (20,429 reports)
Common drugs associated with Conjunctivitis:
- Dupixent: 3,684 reports
- Prednisone: 1,162 reports
- Methotrexate: 851 reports
- Enbrel: 658 reports
- Humira: 652 reports
- Aspirin: 583 reports
- Ibuprofen: 507 reports
- Pantoprazole: 502 reports
- Ibu: 483 reports
- Omeprazole: 476 reports
All the drugs that are associated with Conjunctivitis:
- Conjunctivitis (2,294 drugs)
Common conditions associated with Conjunctivitis:
- Rheumatoid arthritis: 1,148 reports
- High blood pressure: 644 reports
- Asthma: 531 reports
- Crohn's disease: 440 reports
All the conditions that are associated with Conjunctivitis:
- Conjunctivitis (1,608 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fingolimod (the active ingredients of Gilenya) and Gilenya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diazepam and Desonide drug interaction - a second ago
- Imatinib Mesylate and Flatulence - 3 seconds ago
- Ondansetron and Haemorrhoids - 5 seconds ago
- Lorazepam and Nasal Flaring - 6 seconds ago
- Hydrea and Videx drug interaction - 9 seconds ago
- Zoloft and Lasix drug interaction - 9 seconds ago
- Amlodipine and Respiratory Tract Infection Fungal - 14 seconds ago
- Triamcinolone and Skin Blushing/Flushing - 17 seconds ago
- Metformin and Hypercalciuria - 18 seconds ago
- Advair Hfa and Traumatic Lung Injury - 18 seconds ago